Exostar, a specialist in trusted, secure business collaboration in highly-regulated industries including aerospace and defense, life sciences, and healthcare, today announced an agreement with Fujitsu Limited to better protect the controlled unclassified information exchanged by companies throughout the U.S. Department of Defense’s global, multi-tiered supply chain. The agreement brings solutions to the Japanese market that allow Japanese companies that participate in the DoD supply chain to meet the security requirements for accessing and handling CUI found in National Institute of Standards and Technology Special Publication 800-171.
“Our relationship with Fujitsu is important to Exostar, our customers, and our partners across aerospace and defense,” said Stuart Itkin, Exostar’s Vice President of Marketing and Product Management. “It encapsulates our commitment to continually expand and add value to our trusted community of nearly 150,000 A&D organizations worldwide, enabling them to make better, more timely decisions, to mitigate risk, and to operate more efficiently.”
Last month, Fujitsu launched Fort# Forum, a Japanese language defense and national security solution that incorporates Exostar’s Managed Access Gateway identity management platform and ForumPass Defense multi-enterprise information sharing platform, which together enable organizations to comply with key controls under NIST SP 800-171.
As the A&D industry continues to address security challenges on a global basis, Fort# Forum builds the foundation for common practices by providing the means for Japanese companies that are important members of the DoD supply chain to align with U.S. cybersecurity standards.
Exostar’s cloud-based platforms create exclusive communities within highly-regulated industries where organizations securely collaborate, share information, and operate compliantly. Within these communities we build trust. More than 135,000 Aerospace and Defense organizations and agencies in over 150 countries trust Exostar to strengthen security, reduce expenditures, raise productivity, and help them achieve their missions. Ten of the top twenty global biopharmaceutical companies rely on Exostar to help them speed new medicines and therapies to market. Exostar is a Gartner Cool Vendor.
Enjoy curated articles directly to your inbox.